Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
SEC 8-K · Feb 12, 2026 · 130 workers
Ultragenyx Pharmaceutical Inc.
130
Feb 12, 2026
CA, United States
SEC 8-K Item 2.05 costs associated with exit/disposal activities
A securities filing with the U.S. SEC reporting a material workforce or restructuring event, often under Item 2.05 or 5.02.
Ultragenyx Pharmaceutical Inc. filed this with the SEC because investors must be informed promptly about material layoffs, restructuring costs, or executive changes.
SEC 8-K layoff disclosures often arrive after WARN notices but can include restructuring costs, executive changes, and forward guidance that WARN filings omit.
Ultragenyx Pharmaceutical Inc. appears on cutoffs because we link WARN layoffs to employer profiles with visa filings, SEC disclosures, and workforce signals. Open the company profile to see related H-1B activity, SEC filings, and other layoff events.
